Home › Companies › Jazz Pharmaceuticals plc › 2025-2026
Compiled from SEC Form N-PX filings and Jazz Pharmaceuticals plc’s Form 8-K, filed 2025-07-25 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Jazz Pharmaceuticals plc in the interactive database Compare manager voting policies
These tallies are Jazz Pharmaceuticals plc’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-07-25 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jennifer E. Cook | 49,838,761 | 1,472,373 | 31,182 | -- | 4,465,696 | Majority: yes |
| Elect Director: Patrick G. Enright | 49,122,808 | 2,186,963 | 32,545 | -- | 4,465,696 | Majority: yes |
| Elect Director: Seamus Mulligan | 49,488,355 | 1,821,942 | 32,019 | -- | 4,465,696 | Majority: yes |
| Elect Director: Norbert G. Riedel, Ph.D. | 46,521,583 | 4,787,903 | 32,830 | -- | 4,465,696 | Majority: yes |
| Proposal 2: to ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin as our independent auditors for the fiscal year ending December 31, 2025 and to authorize, in a binding vote, our board of directors, acting through the audit committee, to | 54,773,976 | 996,901 | 37,135 | -- | -- | Majority: yes |
| Proposal 3: to approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement | 48,261,149 | 2,887,574 | 193,593 | -- | 4,465,696 | Majority: yes |
| Proposal 4: to grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply | 53,607,244 | 2,159,201 | 41,567 | -- | -- | Majority: yes |
Source: Jazz Pharmaceuticals plc, Form 8-K, filed with the SEC on 2025-07-25 — read the filing on EDGAR.
Each item below shows how the 563 asset managers that disclosed a Jazz Pharmaceuticals plc vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Jazz Pharmaceuticals plc’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2025-07-24.
Combines 18 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Proposal 3: to approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement”): 48,261,149 for, 2,887,574 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 80% for, 5% against (84% of the company cast a for/against vote).
The 549 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,176,997 | 1 | 0 | 0 | For |
| BlackRock | 4,855,082 | 501 | 0 | 0 | For |
| Capital Group | 4,042,492 | 0 | 0 | 0 | For |
| Fidelity | 2,403,005 | 0 | 0 | 0 | For |
| State Street | 1,718,771 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 1,706,469 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,573,540 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,504,445 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 1,464,705 | 0 | 0 | 0 | For |
| JPMorgan | 1,372,277 | 0 | 0 | 0 | For |
| Charles Schwab | 1,168,441 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,162,246 | 0 | 0 | 0 | For |
| Dimensional | 1,085,027 | 0 | 0 | 0 | For |
| Swedbank Robur Fonder AB | 0 | 1,074,092 | 0 | 0 | Against |
| Columbia Threadneedle | 820,993 | 0 | 0 | 0 | For |
| GOLDENTREE ASSET MANAGEMENT LP | 782,280 | 0 | 0 | 0 | For |
| John Hancock | 781,077 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 752,289 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 717,837 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 712,428 | 0 | 0 | 0 | For |
| GMT CAPITAL CORP | 696,500 | 0 | 0 | 0 | For |
| SEI | 622,470 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 623 | 555,704 | 0 | 0 | Against |
| THOMPSON SIEGEL & WALMSLEY LLC | 536,752 | 0 | 0 | 0 | For |
| AQR | 534,092 | 0 | 0 | 0 | For |
Showing the 25 largest of 549 asset managers. See all 549 in the interactive database.
Meeting held 2025-07-24.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Proposal 2: to ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin as our independent auditors for the fiscal year ending December 31, 2025 and to authorize, in a binding vote, our board of directors”): 54,773,976 for, 996,901 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 90% for, 2% against (92% of the company cast a for/against vote).
The 131 asset managers below cast 99.4% of the shares they voted on this item FOR (23,968,052 for, 126,868 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,954,886 | 0 | 0 | 0 | For |
| BlackRock | 2,882,483 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,715,527 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,504,445 | 0 | 0 | 0 | For |
| JPMorgan | 1,365,084 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 820,993 | 0 | 0 | 0 | For |
| Dimensional | 767,053 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 752,289 | 0 | 0 | 0 | For |
| Charles Schwab | 581,372 | 0 | 0 | 0 | For |
| State Street | 460,040 | 0 | 0 | 0 | For |
| TIAA | 370,800 | 0 | 0 | 0 | For |
| Pear Tree Funds | 310,900 | 0 | 0 | 0 | For |
| Transamerica | 307,999 | 0 | 0 | 0 | For |
| SEI | 249,696 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 243,056 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 237,159 | 0 | 0 | 0 | For |
| John Hancock | 233,511 | 0 | 0 | 0 | For |
| American Century | 212,264 | 0 | 0 | 0 | For |
| First Trust | 210,400 | 0 | 0 | 0 | For |
| AQR | 155,517 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 148,583 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,435 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,702 | 126,614 | 0 | 0 | Against |
| Jackson National | 128,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 131 asset managers. See all 131 in the interactive database.
Meeting held 2025-07-24.
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Elect Director: Jennifer E. Cook”): 49,838,761 for, 1,472,373 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 82% for, 2% against (85% of the company cast a for/against vote).
The 129 asset managers below cast 99.0% of the shares they voted on this item FOR (23,827,473 for, 221,758 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,954,886 | 0 | 0 | 0 | For |
| BlackRock | 2,882,483 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,715,527 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,504,445 | 0 | 0 | 0 | For |
| JPMorgan | 1,365,084 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 820,993 | 0 | 0 | 0 | For |
| Dimensional | 767,053 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 752,289 | 0 | 0 | 0 | For |
| Charles Schwab | 581,372 | 0 | 0 | 0 | For |
| State Street | 460,040 | 0 | 0 | 0 | For |
| TIAA | 370,800 | 0 | 0 | 0 | For |
| Pear Tree Funds | 310,900 | 0 | 0 | 0 | For |
| Transamerica | 307,999 | 0 | 0 | 0 | For |
| SEI | 249,696 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 243,056 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 237,159 | 0 | 0 | 0 | For |
| John Hancock | 233,511 | 0 | 0 | 0 | For |
| American Century | 212,264 | 0 | 0 | 0 | For |
| First Trust | 210,400 | 0 | 0 | 0 | For |
| AQR | 155,517 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 148,583 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,435 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,702 | 126,614 | 0 | 0 | Against |
| Jackson National | 128,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.
Meeting held 2025-07-24.
Combines 6 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Elect Director: Norbert G. Riedel, Ph.D.”): 46,521,583 for, 4,787,903 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 77% for, 8% against (85% of the company cast a for/against vote).
The 129 asset managers below cast 94% of the shares they voted on this item FOR (22,718,415 for, 1,330,816 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,954,885 | 1 | 0 | 0 | For |
| BlackRock | 2,882,483 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,715,527 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,504,445 | 0 | 0 | 0 | For |
| JPMorgan | 1,365,084 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 820,993 | 0 | 0 | 0 | For |
| Dimensional | 767,053 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 752,289 | 0 | 0 | 0 | For |
| Charles Schwab | 581,372 | 0 | 0 | 0 | For |
| State Street | 0 | 460,040 | 0 | 0 | Against |
| TIAA | 0 | 370,800 | 0 | 0 | Against |
| Pear Tree Funds | 310,900 | 0 | 0 | 0 | For |
| Transamerica | 307,999 | 0 | 0 | 0 | For |
| SEI | 249,696 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 225,128 | 17,928 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 237,159 | 0 | 0 | 0 | For |
| John Hancock | 233,511 | 0 | 0 | 0 | For |
| American Century | 212,264 | 0 | 0 | 0 | For |
| First Trust | 210,400 | 0 | 0 | 0 | For |
| AQR | 155,517 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 148,583 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,435 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,702 | 126,614 | 0 | 0 | Against |
| Jackson National | 128,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.
Meeting held 2025-07-24.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Elect Director: Patrick G. Enright”): 49,122,808 for, 2,186,963 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 81% for, 4% against (85% of the company cast a for/against vote).
The 129 asset managers below cast 99.0% of the shares they voted on this item FOR (23,809,544 for, 239,687 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,954,885 | 1 | 0 | 0 | For |
| BlackRock | 2,882,483 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,715,527 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,504,445 | 0 | 0 | 0 | For |
| JPMorgan | 1,365,084 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 820,993 | 0 | 0 | 0 | For |
| Dimensional | 767,053 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 752,289 | 0 | 0 | 0 | For |
| Charles Schwab | 581,372 | 0 | 0 | 0 | For |
| State Street | 460,040 | 0 | 0 | 0 | For |
| TIAA | 370,800 | 0 | 0 | 0 | For |
| Pear Tree Funds | 310,900 | 0 | 0 | 0 | For |
| Transamerica | 307,999 | 0 | 0 | 0 | For |
| SEI | 249,696 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 225,128 | 17,928 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 237,159 | 0 | 0 | 0 | For |
| John Hancock | 233,511 | 0 | 0 | 0 | For |
| American Century | 212,264 | 0 | 0 | 0 | For |
| First Trust | 210,400 | 0 | 0 | 0 | For |
| AQR | 155,517 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 148,583 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,435 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,702 | 126,614 | 0 | 0 | Against |
| Jackson National | 128,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.
Meeting held 2025-07-24.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Elect Director: Seamus Mulligan”): 49,488,355 for, 1,821,942 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 82% for, 3% against (85% of the company cast a for/against vote).
The 129 asset managers below cast 99.5% of the shares they voted on this item FOR (23,936,413 for, 112,818 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,954,886 | 0 | 0 | 0 | For |
| BlackRock | 2,882,483 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,715,527 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,504,445 | 0 | 0 | 0 | For |
| JPMorgan | 1,365,084 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 820,993 | 0 | 0 | 0 | For |
| Dimensional | 767,053 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 752,289 | 0 | 0 | 0 | For |
| Charles Schwab | 581,372 | 0 | 0 | 0 | For |
| State Street | 460,040 | 0 | 0 | 0 | For |
| TIAA | 370,800 | 0 | 0 | 0 | For |
| Pear Tree Funds | 310,900 | 0 | 0 | 0 | For |
| Transamerica | 307,999 | 0 | 0 | 0 | For |
| SEI | 249,696 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 225,128 | 17,928 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 237,159 | 0 | 0 | 0 | For |
| John Hancock | 233,511 | 0 | 0 | 0 | For |
| American Century | 212,264 | 0 | 0 | 0 | For |
| First Trust | 210,400 | 0 | 0 | 0 | For |
| AQR | 155,517 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 148,583 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,435 | 0 | 0 | 0 | For |
| ETF Series Solutions | 139,316 | 0 | 0 | 0 | For |
| Jackson National | 128,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.
Meeting held 2025-07-24.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Proposal 4: to grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emptio”): 53,607,244 for, 2,159,201 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 88% for, 4% against (92% of the company cast a for/against vote).
The 127 asset managers below cast 99.6% of the shares they voted on this item FOR (22,558,000 for, 81,518 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,954,886 | 0 | 0 | 0 | For |
| BlackRock | 2,882,483 | 0 | 0 | 0 | For |
| Capital Group | 2,000,000 | 0 | 0 | 0 | For |
| Fidelity | 1,715,527 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,504,445 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 820,993 | 0 | 0 | 0 | For |
| Dimensional | 767,053 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 752,289 | 0 | 0 | 0 | For |
| Charles Schwab | 581,372 | 0 | 0 | 0 | For |
| State Street | 460,040 | 0 | 0 | 0 | For |
| TIAA | 370,800 | 0 | 0 | 0 | For |
| Pear Tree Funds | 310,900 | 0 | 0 | 0 | For |
| Transamerica | 307,999 | 0 | 0 | 0 | For |
| SEI | 249,696 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 225,128 | 17,928 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 237,159 | 0 | 0 | 0 | For |
| John Hancock | 233,511 | 0 | 0 | 0 | For |
| American Century | 212,264 | 0 | 0 | 0 | For |
| First Trust | 210,400 | 0 | 0 | 0 | For |
| AQR | 155,517 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 148,583 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 140,435 | 0 | 0 | 0 | For |
| ETF Series Solutions | 126,614 | 12,702 | 0 | 0 | For |
| Jackson National | 128,687 | 0 | 0 | 0 | For |
| Goldman Sachs | 120,317 | 0 | 0 | 0 | For |
Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.
Meeting held 2025-07-24.
96% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Proposal 4: to grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emptio”): 53,607,244 for, 2,159,201 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 88% for, 4% against (92% of the company cast a for/against vote).
The 4 asset managers below cast 100% of the shares they voted on this item FOR (1,450,797 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 1,365,084 | 0 | 0 | 0 | For |
| Lincoln Financial | 54,484 | 0 | 0 | 0 | For |
| Empower | 30,229 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 1,000 | 0 | 0 | 0 | For |
Meeting held 2026-07-23 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Jazz Pharmaceuticals plc’s own tally for this item (“Proposal 3: to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement”): 50,608,405 for, 3,345,782 against, per its Form 8-K filed 2026-07-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 60,631,000 outstanding shares: 83% for, 6% against (89% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (11 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Prairiewood Capital, LLC | 8 | 0 | 0 | 0 | For |
| Foster Victor Wealth Advisors, LLC | 3 | 0 | 0 | 0 | For |
Meeting held 2025-07-24.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (45,689 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| McGowan Group Asset Management, Inc. | 45,659 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 30 | 0 | 0 | 0 | For |
Meeting held 2025-07-24.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| McGowan Group Asset Management, Inc. | 45,659 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 30 | 0 | 0 | 0 | For |
Ranked by the number of Jazz Pharmaceuticals plc shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 60,631,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.19% |
| 2 | BlackRock | 8.01% |
| 3 | Capital Group | 6.67% |
| 4 | Fidelity | 3.96% |
| 5 | State Street | 2.83% |
| 6 | EcoR1 Capital, LLC | 2.81% |
| 7 | FULLER & THALER ASSET MANAGEMENT, INC. | 2.60% |
| 8 | Capitol Series Trust | 2.48% |
| 9 | LSV ASSET MANAGEMENT | 2.42% |
| 10 | JPMorgan | 2.26% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 9.76% | 13F |
| BlackRock | 9.22% | 13F |
| FMR (Fidelity) | 3.75% | 13F |
| Franklin Templeton | 3.23% | 13F |
| Dimensional Fund Advisors | 3.13% | 13F |
| State Street | 3.12% | 13F |
| BNY Mellon | 2.77% | 13F |
| Citadel Advisors | 2.22% | 13F |
| Seamus C. Mulligan | 2.15% | DEF14A |
| Bruce C. Cozadd | 1.28% | DEF14A |
Percentages above are of 60,631,000 shares outstanding, as reported by Jazz Pharmaceuticals plc on its Form 10-K dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Jazz Pharmaceuticals plc’s 10-K dated 2024-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Jazz Pharmaceuticals plc's shareholder meeting held 2025-07-24, in the 2025-2026 proxy season, 563 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,958 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's… — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Jazz Pharmaceuticals plc's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-07-25.
Jazz Pharmaceuticals plc proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).